Table 1. . Clinico-pathological features of lung cancer patients.
| Characteristics | ADCs, n = 75 (%) | SQCCs, n = 88 (%) |
|---|---|---|
| Gender | ||
| Male | 38 (50.7%) | 58 (65.9%) |
| Female | 37 (49.3%) | 30 (34.1%) |
| Age (years) | ||
| Median | 63 | 64.5 |
| Range | 45–86 | 40–81 |
| Tumor size (cm) | ||
| Average | 3.09 | 4.35 |
| Range | 0.5–9.0 | 1.0–11.0 |
| Differentiation grade | ||
| Well | 9 (12.0%) | 4 (4.5%) |
| Moderate | 51 (68.0%) | 60 (68.2%) |
| Poor | 15 (20.0%) | 24 (27.3%) |
| Smoking status | ||
| Non-smokers | 15 (20.0%) | 11 (12.5%) |
| Smokers† | 60 (80.0%) | 77 (87.5%) |
| Pathological stage | ||
| pT1 | 38 (50.7%) | 24 (27.3%) |
| pT2 | 31 (41.3%) | 28 (31.8%) |
| pT3 | 5 (6.7%) | 25 (28.4%) |
| pT4 | 1 (1.3%) | 11 (12.5%) |
| EGFR/KRAS status | ||
| Non-mutation | 66 (88.0%) | – |
| Mutation | 9 (12.0%) | – |
| Survival time (months) | ||
| Median | 54 | 46 |
| Range | 0–140 | 0–208 |
†
Includes both current and former smokers.
ADC: Adenocarcinoma; SQCC: Squamous cell carcinoma.